Mirum Pharmaceuticals (mirm 4 05/01/29)
13F holders, Q2 2025 (June 30)3holders
0new positions
0sold out
$1.77avg. 13F price*
At the end of Q2 2025, 3 institutions reported holding Mirum Pharmaceuticals (mirm 4 05/01/29) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were Sei Investments Co. ($404K), Oppenheimer Asset Management Inc. ($110K) and Stephens Inc. ($35K).
- Company
- Mirum Pharmaceuticals (mirm 4 05/01/29)
- CUSIP
- 604749AB7
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 3 holders
| Sei Investments Co. | 0.00% | No change | 228,000 | $404K |
| Oppenheimer Asset Management Inc. | 0.00% | No change | 62,000 | $110K |
| Stephens Inc. | 0.00% | No change | 20,000 | $35K |
"% of holder's portfolio" is MIRUM PHARMACEUTICALS (MIRM 4 05/01/29)'s weight in each manager's 13F, not the share of Mirum Pharmaceuticals (mirm 4 05/01/29) the manager owns.